Literature DB >> 18350477

[The role of patient flow and surge capacity for in-hospital response in mass casualty events].

Peter Sefrin1, Herbert Kuhnigk.   

Abstract

Mass casualty events make demands on emergency services and disaster control. However, optimized in- hospital response defines the quality of definitive care. Therefore, German federal law governs the role of hospitals in mass casualty incidents. In hospital casualty surge is depending on resources that have to be expanded with a practicable alarm plan. Thus, in-hospital mass casualty management planning is recommended to be organized by specialized persons. To minimise inhospital patient overflow casualty surge principles have to be implemented in both, pre-hospital and in-hospital disaster planning. World soccer championship 2006 facilitated the initiation of surge and damage control principles in in-hospital disaster planning strategies for German hospitals. The presented concept of strict control of in-hospital patient flow using surge principles minimises the risk of in-hospital breakdown and increases definitive hospital treatment capacity in mass casualty incidents.

Entities:  

Mesh:

Year:  2008        PMID: 18350477     DOI: 10.1055/s-2008-1070975

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  2 in total

1.  [Pretreatment mass casualty incident workflow analysis : Comparison of two level 1 trauma centers].

Authors:  F Mück; K Wirth; M Muggenthaler; K G Kanz; U Kreimeier; D Maxien; U Linsenmeier; W Mutschler; S Wirth
Journal:  Unfallchirurg       Date:  2016-08       Impact factor: 1.000

2.  [A million football fans in a city of 120,000 inhabitants--a nightmare for emergency medicine and disaster management? Euro 2008 and the "Orange wonder of Berne"].

Authors:  L Martinolli; E Tanyeli; R M Hasler; P Burkhardt; H Bähler; F Neff; P Rupp; H Zimmermann; A K Exadaktylos
Journal:  Unfallchirurg       Date:  2011-01       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.